Finapark Tablet 50 mg contains Safinamide Mesylate, a therapeutic agent indicated for the management of Parkinson’s disease. It is designed to improve motor function by modulating dopaminergic activity in the brain. Parkinson’s disease is a progressive neurological disorder characterized by tremors, rigidity, and bradykinesia, caused by depletion of dopamine. Safinamide Mesylate works through dual mechanisms—selective inhibition of monoamine oxidase-B (MAO-B) and modulation of glutamate release—to enhance dopamine levels and reduce motor fluctuations.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features and Benefits
Active Ingredient:

• Safinamide Mesylate 50 mg per tablet, a potent, orally active MAO-B inhibitor.

Mechanism of Action:

• MAO-B Inhibition: Safinamide selectively inhibits monoamine oxidase-B, the enzyme responsible for dopamine breakdown in the brain. By reducing dopamine degradation, it increases dopaminergic activity, helping to alleviate Parkinson’s symptoms.

• Glutamate Modulation: Safinamide also regulates excessive glutamate release, which may contribute to its ability to reduce dyskinesia and motor complications.

Clinical Benefits:

• Improves “on” time and reduces “off” time in patients experiencing motor fluctuations while on levodopa therapy.

• Helps enhance overall motor performance, including movement initiation, coordination, and control.

• May contribute to improved quality of life due to better symptom management.

Usage and Indications:
Finapark Tablet 50 mg is prescribed as an adjunct therapy to levodopa/carbidopa in patients with Parkinson’s disease who experience motor fluctuations. The medication is typically initiated once daily with or without food. Dosage adjustments are made based on clinical response and tolerability.

Dosage and Administration:

• The usual starting dose is 50 mg once daily.

• Healthcare providers may increase the dose to 100 mg once daily based on patient response, tolerance, and clinical judgment.

• It should be taken at the same time each day to maintain consistent plasma levels.

• Swallow the tablet whole with water; do not crush or chew.

Safety and Precautions:
Contraindications:

• Hypersensitivity to Safinamide or any component of the formulation.

• Concurrent use of non-selective MAO inhibitors or other contraindicated medications due to risk of hypertensive crisis.

Warnings:

• Monitor for signs of serotonin syndrome if used with serotonergic agents.

• Caution in patients with severe hepatic impairment.

• Blood pressure changes should be observed, particularly in patients with cardiovascular disorders.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects:
Common side effects may include nausea, dizziness, insomnia, headache, and dyskinesia. These are generally mild to moderate and often diminish over time. Report any severe or persistent symptoms to a healthcare provider.

Drug Interactions:
Safinamide Mesylate may interact with certain antidepressants, sympathomimetics, and other MAO-active substances. It is essential to inform healthcare professionals of all medications, supplements, and herbal products being used to avoid potential interactions.

Patient Counseling Information:
Patients should be advised to:

• Take Finapark Tablet as prescribed.

• Not discontinue therapy abruptly without consulting a physician.

• Report any unusual symptoms, such as severe agitation, confusion, or uncontrolled movements.

• Be aware that improvement may take several weeks.

Storage:
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Conclusion:
Finapark Tablet 50 mg (Safinamide Mesylate) offers a valuable option in the management of motor fluctuations associated with Parkinson’s disease, enhancing the effectiveness of levodopa therapy and improving patient outcomes when used under medical supervision.